PAP
INSM icon

Persistent Asset Partners’s Insmed INSM Stock Holding History

Persistent Asset Partners’s Portfolio INSM Stock Details INSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-3,692
Closed -$643K – 400
2025
Q4 		$643K Buy
+3,692
New +$674K 0.29% 97
2025
Q3 		– Sell
-8
Closed -$805 – 270
2025
Q2 		$805 Buy
+8
New +$612 ﹤0.01% 179
2025
Q1 		– Sell
-12,500
Closed -$957K – 193
2024
Q4 		$957K Buy
+12,500
New +$900K 0.79% 38

Other funds holding INSM

JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.77B AUM 307.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Persistent Asset Partners's INSM Position: Q1 2026 in Review

Persistent Asset Partners sold out of Insmed (INSM) in Q1 2026, closing a stake of 3,692 shares — an estimated $643K sold.

Persistent Asset Partners first reported a position in INSM in Q4 2024 and held it in 3 quarters. The position peaked at $957K in Q4 2024. 669 funds tracked by Wall St. Rank hold INSM as of Q1 2026.

  • Persistent Asset Partners reported no remaining Insmed position as of Q1 2026 after selling out during the quarter.
  • Persistent Asset Partners sold 3,692 Insmed shares in Q1 2026, an estimated $643K.
  • Persistent Asset Partners first reported a position in Insmed in Q4 2024 and held it in 3 quarters.
  • Persistent Asset Partners's Insmed position peaked at $957K in Q4 2024.
  • 669 funds tracked by Wall St. Rank held Insmed as of Q1 2026.

Based on Persistent Asset Partners's 13F filing for Q1 2026, filed 12 May 2026.